Diabetes Champion Course #15 (Live)

September 9, 2019 to September 12, 2019

Program Description

The Diabetes Champion Course provides training for primary care teams (provider & support staff) to assess and improve the diabetes care provided at their respective MTF. Focus is on increasing individual knowledge, assessing clinical processes, facilitating team dynamics, and developing and implementing quality improvement initiatives. Presentations are evidence-based, case-driven, and provided by subject matter experts to increase knowledge and expertise of all participants, bridging the knowledge gap between diabetes specialists and the primary healthcare providers at the MTFs.

Target Audience

This activity is designed to meet the educational needs of Physicians, Nurses, Pharmacists, Pharmacy Technicians, Physician Assistants, Registered Dietitians, Diet Techs, and other health care professionals who support/ care for U.S. active-duty service members, reservists, National Guardsmen, military veterans and their families.

Learning Objectives

  1. Discuss the scope of diabetes.
  2. Define/describe role of Diabetes Champion.
  3. Outline strategies to facilitate change in the care system.
  4. Identify gaps of care as determined by MTF pre-assessment.
  5. Develop an action plan.
  6. Describe principles of evidenced- based practice.
  7. Discuss treatment recommendations for diabetes.
  8. Summarize resources to provide support to the multidisciplinary team.
  9. Discuss recognition and treatment of hypoglycemia.
  10. Outline the role of insulin in treating/managing PWD.
  11. Develop strategies for initiation of insulin therapy.
  12. Discuss the research supporting primary diabetes prevention.
  13. Summarize CDC and GLB prevention programs.
  14. Summarize the prevention, recognition, and treatment of cardiovascular complications of diabetes.
  15. Outline the prevention, recognition, and treatment of microvascular complications of diabetes.
  16. Define classes oral/injectable medications, explain use to treat type 2 diabetes and assess effectiveness.
  17. State factors to consider when prescribing medications to treat diabetes and determine proper management.
  18. Identify skills techniques for diabetes management (i.e. foot exam, pen devices, etc.).
  19. Explain the importance of preconception counseling for women with diabetes of childbearing age.
  20. Summarize implication of a diagnosis of diabetes for the active duty patient.
  21. Review current recommendations for medical nutritional therapy (MNT) for people with diabetes (PWD).
  22. Summarize exercise/physical activity recommendations for PWD.
  23. Outline strategies for providing Diabetes Self-Management Education and Support (DSMES) to PWD.
  24. Summarize strategies for assessment of psychological and social situation.
  25. Outline considerations for PWD when scheduling elective surgeries.
  26. Evaluate a pediatric patient with overweight/obesity for secondary causes and co-morbidities.
  27. Summarize the Primary Care role in the management of the pediatric diabetes patient.
  28. Analyze the healthcare team workflow, roles and actions in the management of a PWD.
Course summary
Available credit: 
  • 23.00 AAPA
    DHA J-7 CEPO has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 23.00 hours of AAPA Category 1 CME credits. Physician assistants should only claim credit commensurate with the extent of their participation.
  • 23.00 ACPE Pharmacist
    UAN JA4008136-0000-19-094-L04-P
    No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacists. This knowledge based activity will provide a maximum of 23.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
  • 23.00 ACPE Pharmacy technician
    UAN JA4008136-0000-19-094-L04-T
    No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacy Technicians. This knowledge based activity will provide a maximum of 23.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
  • 23.00 AMA PRA Category 1 Credit™
    DHA J-7 CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. DHA J-7 CEPO designated this activity for a maximum of 23.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 23.00 ANCC
    DHA J-7 CEPO is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. DHA J-7 CEPO designated this activity. Continuing Nursing Education activity for a maximum of 23.00 contact hours Nurses should only claim credit commensurate with the extent of their participation in the activity.
  • 23.00 APA
    Continuing Education (CE) credits for psychologists are provided through the co- sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibly for the content of the programs. DHA J-7 CEPO designated this activity for a maximum of 23.00 CE credits. The instructional level of this activity is intermediate. There is no cost to participate.
  • 23.00 Certificate of Attendance
  • 23.00 IPCE
    This activity was planned by and for the healthcare team, and learners can receive up to 23.00 Interprofessional Continuing Education (IPCE) credits for learning and change. In support of improving patient care, this activity has been planned and implemented by DHA J-7 CEPO. DHA, J-7, CEPO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), the American Academy of Physician Assistants (AAPA), the Association of Regulatory Boards of Optometry's Council on Optometric Practitioner Education (ARBO/COPE), the Association of Social Work Boards (ASWB), the American Psychological Association (APA), and the American Dental Association’s Continuing Education Recognition Program (ADA CERP) to provide continuing education for the health care team.
Course opens: 
09/09/2019
Course expires: 
09/12/2019
Event starts: 
09/09/2019 - 20:00
Event ends: 
09/12/2019 - 12:00

CONTINUING HEALTH EDUCATION OUTLINE DCC #15 (Sept 10-13, 2019)

Day 1

LEARNING OBJECTIVESCONTENTTEACHING MINUTES/CONTACT HOURSFACULTY/PRESENTERTEACHING METHODS/INSTRUCTIONAL MEDIA/EVALUATION PLAN
0800-0815 Welcome

Discuss course requirements, methods of instruction, expectations of student/instructor performance and conduct, outcomes measures and CE credit hours awarded

  • CE Disclosure statement
  • Orientation to base and WHASC
  • Course requirements
  • Course materials and CE hours awarded
  • Measures of outcomes (pre-assessment, 30-day survey, 8-month post-assessment, practical application)
  • Introduce CPG/QI Implementation Activity
0 minConnie Morrow, MAEd-AET, DCOE OutreachLecture/PowerPoint slides
0815-0945 Scope of Diabetes, Role of Champion
  1. Discuss the scope of diabetes
  2. Define/describe role of Diabetes Champion
  3. Outline strategies to facilitate change in the care system
  4. Summarize benefits of having a champion and CPG team
  5. Distinguish strategies to optimize provider and team behavior
  6. Compare strategies to support patient behavior change
  7. Introduce CPG/QI project requirement for course participation (part 1)
  8. Analyze findings of previous courses
  • Incidence Direct costs Indirect costs Quality of life
  • Challenges in AFMS
  • Role and duties of Diabetes Champion Implementation strategies
    • Secure executive buy-in
    • Develop/implement action plan
      • Team identification
      • Data collection
    • Facilitate Change
      • Identify barriers
      • Provide training
    • Monitor progress
      • Identify metrics
  • Delineating Staff roles/responsibilities
  • Implementing a system for planned visits for diabetes care
  • Supporting the use of evidence-based guidelines Identify resources
  • Using the patient registry (CarePoint)
  • Incorporating diabetes management self-education and support into every visit
  • Expectations for course clinical practice guideline/quality improvement (CPG/QI) project
  • Previous course and participant examples
  • Previous participant findings: Identifying barriers and finding solutions.
90 minMaj Darrick Beckman, MDLecture/PowerPoint slides Handouts
1000-1130 Current Evidence-Based Practice Guidelines in Diabetes

 

  1. Identify risk factors and metabolic defects in diabetes and pre-diabetes
  2. Describe principles of evidenced- based practice
  3. Summarize the clinical practice guidelines from the VADOD and American Diabetes Association
  4. Discuss treatment recommendations for diabetes
  • Normal glucose metabolism Pre-diabetes: IGF, IGT Diabetes: Type 1, Type 2, other Glycemic goals in diabetes
  • Diagnosis of diabetes and pre-diabetes
  • Sources of evidence-based practice to guide clinical practice of diabetes management
  • VADOD Diabetes Clinical Practice Guideline
  • American Diabetes Association 2019 Medical Standards of Care
  • Treatment goals for HTN and HLP
  • Treatment algorithms
90 minDr. Tom SauerweinLecture/PowerPoint slides/Student Handouts
1230-1315 Professional and Community Resources for Diabetes Management
  1. Identify diabetes services covered by TRICARE
  2. Summarize resources to provide support to the multidisciplinary team
  3. Outline programs at DCOE for patient and provider educational opportunities
  • Diabetes Services available through TRICARE Professional Resources
    • CDC
    • AMEDD
    • CEMM Programs
    • Diabetes Central
    • Project ECHO (Diabetes and Prevention)
    • DCS Webinars
45 minKaren Rader, RNLecture/PowerPoint slides Demonstration of Diabetes Central
Demonstration of Center of Excellence for Medical Multimedia
Handouts

 

1330-1400 Overview of Acute Complications of Diabetes
  1. Discuss recognition and treatment of hypoglycemia
  2. Outline strategies for sick day management
  3. Summarize recognition and treatment of life-threatening acute complications
Acute complications of diabetes
  • Hypoglycemia
  • Hyperglycemia(DKA)
  • Concurrent illness (sick days)
30 minMaj Darrick Beckman, MDHandouts
Case Studies (Interactive Participation)
Lecture/PowerPoint slides
1415-1515 Pharmacotherapy: Insulin Therapy
  1. Outline the role of insulin in treating/managing PWD
  2. Compare the types of insulin available
  3. Analyze the strategies for dosing and titrating insulin
Types of insulin and insulin analogs

 

  • Onset, duration, precautions,pt education
  • Insulin devices
  • Pens
Pumps Dosing/titrating insulin Pattern management
60 minLTC Sky Graybill, MDLecture/PowerPoint slides Titration worksheets
1530-1630 Pharmacotherapy: Insulin Therapy
  1. Compare strategies for initiating insulin
  2. Outline titration/dosing of insulin
  3. Demonstrate recognition of blood glucose patterns that could influence insulin dosing
  • Presentation of case studies
    • When to initiate insulin
    • Recognition of blood glucose patterns
    • Strategies to titrate insulin
  • Patient self-titration
  • Case study 1 (Insoljin)
    • Assessment of health status
    • Medication considerations
  • Psychosocial considerations
60 minLTC Sky Graybill, MD
Nina Watson, RN
Lecture/PowerPoint slides
Case Studies (Interactive Participation)
Group Discussion

 

Day 2

0800-0915 Pre-diabetes and Diabetes Prevention
  1. Discuss the research supporting primary diabetes prevention. CDC and GLB prevention programs
  2. Outline implementation of a diabetes prevention and/or GLB program
  • Review of diabetes prevention research
    • DPP
    • DPPOS
    • GLB/DPSC
  • Discuss available prevention programs Facilitator Training
    • Recommendations for MTF implementation
75 minMaj Maria Kravchenko, MD
Lorena Urbina, CPT/CES
Lecture/PowerPoint slides
Handouts
DVD/CD 2 demonstration
Interactive Participation
0930-1030 Overview of Complications: Chronic
  1. Summarize the prevention, recognition, and treatment of cardiovascular complications of diabetes
  2. Outline the prevention, recognition, and treatment of microvascular complications of diabetes
  3. Analyze the significance of tobacco cessation
  • Chronic complications of diabetes
    • Microvascular
    • Macrovascular
  • Preventative screening
  • Smoking Cessation Immunizations
60 minMaj Philip Clerc, MDLecture/PowerPoint slides Handouts
Case Studies (Interactive Participation)
1045-1200 Pharmacotherapy: Non-Insulin Medications
  1. Define classes oral/injectable medications, explain use to treat type 2 diabetes and assess effectiveness
  2. State factors to consider when prescribing medications to treat diabetes and determine proper management
  3. Apply VA/DOD sequential approach plan medical management of diabetes
  4. Recognize elements in clinical case study to construct treatment plan
  • Reasons for monitoring Continuous glucose monitoring Interpreting the numbers
  • Classifications of diabetes medications
    • Purpose, action, dosing, side effects, precautions, patient education
    • Oral: Biguanides, sulfonylureas, TZDs, Alpha-glucosidase inhibitors, glinides, DPP-4 inhibitors, SGLT2 inhibitors, bile acid sequestrants
    • Injectable: incretin mimetics, amylin analogs
  • Management of medication regimens
  • Pattern management
75 minMaj Craig Jenkins, MDLecture/PowerPoint slides Handouts
Case Studies (Interactive Participation)

 

1300-1530 Skills for Diabetes Management
  1. Validate assessment skill for a comprehensive foot exam
  2. Demonstrate techniques and data download for glucose monitoring devices
  3. Identify techniques of pen injector devices and glucagon instruction
  4. Show the function of insulin pumps and continuous glucose monitoring devices
  • Part 1: Comprehensive foot exam
  • Part 2: Glucose monitoring devices (patient use and downloading)
  • Part 3: Pen injector device & Glucagon teaching Strategies
  • Part 4: Insulin pumps & Continuous Glucose Monitoring Systems
120 minDonald Cobb, LVN
Dave Beavers, RN
Karen Rader, RN
Timothy Corbin, PharmD
Adamaris Rivera-Santiago, PharmD
Ellen Cobb, RN
Jana Wardian, PhD
Group Demonstration/Return demonstration Handouts
1530-1630 CPG/QI: Discuss & Develop (part 2)
  1. Discuss identified gaps in practice
  2. Develop an action plan
  3. Apply strategies to implement action plan
  • Practical application of:
    • Implementation strategies
    • Identify Diabetes Team
  • Develop strategies to implement action
60 minNina Watson, RN
Connie Morrow, MAEd
Small Group Activity/Discussion

 

Day 3

0800-0915 Reproductive Health in Women with Diabetes
  1. Explain the importance of preconception counseling for women with diabetes of childbearing age
  2. Summarize the importance of glucose management before, during, and after pregnancy
  3. Identify the diabetes/hypertensive/ cholesterol medications contraindicated during pregnancy
  4. Discuss follow-up of women with gestational diabetes post pregnancy
  • Preconception Care/Counseling
  • Implications of poor glucose control on pregnancy
  • Medications contraindicated during pregnancy
  • Post-partum considerations
  • Gestational Diabetes
75 minLt Col Larissa Weir, MDLecture/PowerPoint slides
Case Studies (Interactive Participation)
0930-1030 Case Studies 1-2
  1. Analyze the healthcare team workflow, roles and actions in the management of a PWD
  2. Discuss strategies for initiation of insulin therapy
  3. Summarize implication of a diagnosis of diabetes for the active duty patient
  4. Review Military Evaluation Board (MEB) process
  • Case study 1 (Babbe)
    • Assessment of health status
    • Medication considerations
    • Psychosocial considerations
    • Preconception Counseling
    • Medical Evaluation Board process
  • Case study 2 (Pennerknie)
    • Assessment of health status
    • Medication considerations
    • Psychosocial considerations
    • Medical Evaluation Board process
60 minMaj Darrick Beckman, MDPowerPoint slides
Group Participation Case Study
1030-1045 CPG/QI: Q&A (Part 3)
  1. Describe MTF action plan
  2. Identify gaps in practice
  3. Explain strategies to implement action plan
Question and Answer session15 minKaren Rader, RNParticipant presentations
Group Discussion

 

1100-1200 Lifestyle Management (1): Nutritional Guidelines
  1. Review current recommendations for medical nutritional therapy (MNT) for people with diabetes (PWD)
  2. Distinguish the goals of nutrition therapy for PWD
  3. Compare strategies to facilitate healthy eating behaviors
  • CPG recommendations for MNT (VA/DoD, ADA, AND)
  • Healthy eating instruction
  • Meal planning strategies: Carb Counting, Food Guide Pyramid, Plate Method, Glycemic Index
60 minDenise Sprague, RDLecture/PowerPoint slides Handouts
Carb calculation practice
1300-1345 Lifestyle Management (2): Physical Activity
  1. Summarize exercise/physical activity recommendations for PWD
  2. List strategies to facilitate behavior change to increase activity level
  3. Identify ways to reduce risk of hypoglycemia during exercise
  • Expected benefits: weight, lipids, glucose control, BP in Type 1, Type 2 and pre-diabetes
  • Frequency and type of exercise Exercise and Glycemic control
  • Presence of non-optimal glycemic control
45 minLorena Urbina, CPT/CESLecture/PowerPoint slides
Handouts
1400-1500 Lifestyle Management (3): Diabetes Self-Management Education and Support

 

  1. Review current CPG (VA/DoD, ADA) recommendations for lifestyle management
  2. Outline strategies for providing Diabetes Self-Management Education and Support (DSMES) to PWD
  • Review of research supporting diabetes education
  • Define level of diabetes education providers
  • Current standards of care/CPG recommendations
    • Group vs individual
    • Defining “support”
  • Process for recognition and reimbursement.
60 minEllen Cobb, RNLecture/PowerPoint slides
Handouts
1515-1630 Lifestyle Management (4): Psychosocial Assessment and Care

 

  1. Summarize strategies for assessment of psychological and social situation>
  2. Identify resources available for assessment and management of psychosocial issues in PWD
  3. Analyze strategies to facilitate behavioral change
  • Review of psychological and social problems associated with diabetes
  • Identifying depression
  • Use of BHOP in the PCMH
  • Barriers to self-care
  • Review of Motivational Interviewing techniques. Presentation of scenarios/case studies to facilitate discussion.
  • Guided practice session for participants.
75 minAnn Hryshko- Mullen, PhD
Capt Blue Star, PhD
Slides
Group Participation Case Study

 

Day 4

0800-0900 Managing Pre/Post Hospitalization
  1. Outline considerations for PWD when scheduling elective surgeries
  2. Summarize changes in medication regimens for known surgical or diagnostic procedures
  3. Compare strategies for follow-up post hospitalization
  • Pre-operative evaluation (suitability)
  • Medication management changes in peri-operative care
    • Orals
    • Insulin
  • Re-establishing the “home” regimen of medical care
60 minMaj Jeffrey Colburn, MDLecture/PowerPoint slides
0915-1030 Managing the pediatric diabetes patient
  1. Describe the obesity epidemic in the US and the world
  2. Define obesity in children and how to make the diagnosis
  3. Evaluate a pediatric patient with overweight/obesity for secondary causes and co morbidities
  4. Discuss and apply techniques utilizing motivational interviewing in the encounter with an overweight/obese patient
  5. Summarize the Primary Care role in the management of the pediatric diabetes patient
  • Managing the Pediatric Diabetes Patient
  • Childhood obesity
  • Rates of childhood obesity
  • Cycle of childhood obesity
  • Importance
  • Barriers to discussing and treating obesity
  • Healthy Habits Clinic
  • Readiness to Change
  • Motivation Interviewing
  • Goal Setting
  • ADA Criteria for T1DM and T2 DM
  • Special considerations for pediatric patients
  • Federal and State laws and regulations on equal Access
  • Management of pediatric sick days
  • BG Management Goals
75 minLt Col John Oberlin, MD
Lt Col Candace Percival, MD
Lecture/PowerPoint slides

1040-1110 Case Study

  1. Analyze the healthcare team workflow, roles and actions in the management of a PWD
  2. Develop strategies for initiation of insulin therapy
  • Case study 3 (Foote)
  • Assessment of health status
  • Medication considerations
    • Regimen
    • hypoglycemia
  • Psychosocial considerations
30 minMaj Jeffrey Colburn, MDGroup Participation Case Study
1110-1140 CPG/QI: Presentations (part 4)
  1. Describe MTF action plan.
  2. Identify gaps in practice
  • Practical application of:
    • Implementation strategies
    • Identify Diabetes Team
  • Present strategies to implement action plan
30 minKaren Rader, RNParticipant presentations/Group Discussion
1200-1300 Participate in ECHO™ Conference
  • ECHO™ conference: Diabetes and Obesity
0 minConnie Morrow, MAEdLecture/PowerPoint slides via Video Tele-conference
Case study
1300-1330 Program Feedback/Surveys
  • Collect evaluations
  • Question and Answer
  • Distribute certificates/Dismissal
0 minOutreach TeamInteractive

Total CE hours:  23 

San Antonio, TX
United States

 

Disclosure

  • Maj Darrick Beckman, MD has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • LTC Sky Graybill, MD has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • Maj Maria Kravchenko, MD has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • Lorena Urbina, MS, CPT, CES, Prn-1 has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • Nina Watson RN, MSN, CDE has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • Jana Wardian, PhD, MSW has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • Tom J Sauerwein, MD has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • David Beavers, RN has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • Capt. Timothy Corbin, PharmD has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • Capt. Adamaris Rivera Santiago, PharmD has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • Col. Karen Rader, RN has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • Donald B. Cobb, LVN has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • Ellen Cobb, RN has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • Lt Col Larissa Weir, MD has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • Ann Hryshko-Mullen, PhD has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • Denise Sprague, RD has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • Capt Blue Star, PhD has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • Connie C. Morrow, MAEd-AET, CRT has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • Capt Philip Clerc, MD has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • Maj Jeffrey Colburn, MD has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • Maj. Craig Jenkins, MD has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • Lt. Col. Candace Percival has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • Lt. Col. John Oberlin, MD has no relevant financial or non-financial relationships to disclose relating to the content of this activity.
  • The views expressed in this presentation are those of the author and do not necessarily reflect the official policy or position of the Department of Defense (DoD), nor the U.S. Government.
  • This continuing education activity is managed and accredited by the Defense Health Agency J-7 Continuing Education Program Office (DHA J-7 CEPO). DHA J-7 CEPO and all accrediting organizations do not support or endorse any product or service mentioned in this activity.
  • DHA J-7 CEPO staff, as well as activity planners and reviewers have no relevant financial or non-financial interest to disclose.
  • Commercial support was not received for this activity.

Available Credit

  • 23.00 AAPA
    DHA J-7 CEPO has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 23.00 hours of AAPA Category 1 CME credits. Physician assistants should only claim credit commensurate with the extent of their participation.
  • 23.00 ACPE Pharmacist
    UAN JA4008136-0000-19-094-L04-P
    No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacists. This knowledge based activity will provide a maximum of 23.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
  • 23.00 ACPE Pharmacy technician
    UAN JA4008136-0000-19-094-L04-T
    No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacy Technicians. This knowledge based activity will provide a maximum of 23.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
  • 23.00 AMA PRA Category 1 Credit™
    DHA J-7 CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. DHA J-7 CEPO designated this activity for a maximum of 23.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 23.00 ANCC
    DHA J-7 CEPO is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. DHA J-7 CEPO designated this activity. Continuing Nursing Education activity for a maximum of 23.00 contact hours Nurses should only claim credit commensurate with the extent of their participation in the activity.
  • 23.00 APA
    Continuing Education (CE) credits for psychologists are provided through the co- sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibly for the content of the programs. DHA J-7 CEPO designated this activity for a maximum of 23.00 CE credits. The instructional level of this activity is intermediate. There is no cost to participate.
  • 23.00 Certificate of Attendance
  • 23.00 IPCE
    This activity was planned by and for the healthcare team, and learners can receive up to 23.00 Interprofessional Continuing Education (IPCE) credits for learning and change. In support of improving patient care, this activity has been planned and implemented by DHA J-7 CEPO. DHA, J-7, CEPO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), the American Academy of Physician Assistants (AAPA), the Association of Regulatory Boards of Optometry's Council on Optometric Practitioner Education (ARBO/COPE), the Association of Social Work Boards (ASWB), the American Psychological Association (APA), and the American Dental Association’s Continuing Education Recognition Program (ADA CERP) to provide continuing education for the health care team.
Please login or register to take this course.